Decoding directional genetic dependencies through orthogonal CRISPR/Cas screens

Abstract

SummaryGenetic interaction studies are a powerful approach to identify functional interactions between genes. This approach can reveal networks of regulatory hubs and connect uncharacterised genes to well-studied pathways. However, this approach has previously been limited to simple gene inactivation studies. Here, we present an orthogonal CRISPR/Cas-mediated genetic interaction approach that allows the systematic activation of one gene while simultaneously knocking out a second gene in the same cell. We have developed this concept into a quantitative and scalable combinatorial screening platform that allows the parallel interrogation of hundreds of thousands of genetic interactions. We demonstrate that the established platform works robustly to uncover genetic interactions in human cancer cells and to interpret the direction of the flow of genetic information.peer-reviewed)

Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis

“…However, in the context of mammalian metabolism the SKO CRISPR approach comes with limitations, as redundancies and plasticity of the metabolic network may allow the system to remodel around a SKO, thereby confounding analyses of impact on cellular fitness. To overcome this challenge, our group and others recently developed combinatorial gene knockout screening approaches which may provide a more suitable platform to study gene dispensability and also systematically map their interactions (Boettcher et al, 2017; Chow et al, 2017; Han et al, 2017; Shen et al, 2017; Wong et al, 2016).…”

Cell division cycle 7 kinase is a negative regulator of cell-mediated collagen degradation

“…Single cell clones were verified by flow cytometry for a single high peak of BFP expression after 3-4 wk of growth. Sequences against Endo180 or a nontargeting control (Table 1) were cloned into a pSicoR-puro-mCherry backbone under a U6 promoter for singleguide RNA (sgRNA) synthesis, which was a gift from Michael McManus (6). Plasmids were synthesized into lentiviral particles by University of California, San Francisco ViraCore.…”

CRISPR-based genetic interaction maps inform therapeutic strategies in cancer

“…Our strategy first identified high-confidence hit genes using an ultracomplex shRNA library for a specific phenotype following which we generated double-shRNA libraries to construct a GI map between the gene-pairs. More recently, similar approaches have been implemented based on CRISPR technology, including CRISPR-cutting (17–20), CRISPRi (21,22) and CRISPRa (23). We recently demonstrated that combined gain-and-loss of function GI maps leveraging orthogonal CRISPR cutting and CRISPRa approaches can enable the elucidation of directional pathway information (23).…”